Clinically Rich Real-World Data

Enables study of all oncology types and subtypes including solid tumors, blood cancers, rare diseases, and biomarker-defined groups.

 

Enables research across the full spectrum of hematologic conditions such as anemias, thrombocytopenia, sickle cell disease, hemophilia, and polycythemia vera.

 

Supports investigation of major and rare neurological disorders including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, ALS, and other neurodegenerative and neuromuscular conditions.

Enables study of digestive and hepatic diseases ranging from GERD and IBS to inflammatory and metabolic conditions such as Crohn’s disease, ulcerative colitis, and MASH or NASH. 

 

Supports research across autoimmune and inflammatory rheumatic diseases including rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, Sjogren’s syndrome, and gout.

Enables analysis across common and complex skin disorders such as acne, atopic dermatitis, psoriasis, hidradenitis suppurativa, and prurigo nodularis while supporting broader dermatologic research.

 

Supports investigation across a wide range of rare and ultra-rare conditions, with examples including cystic fibrosis, spinal muscular atrophy, Duchenne muscular dystrophy, polycythemia vera, and ALS.

 

Enables research across cardiovascular diseases including hypertension, heart failure, atrial fibrillation, coronary artery disease, and pulmonary arterial hypertension as well as other complex cardiac conditions.

Supports study of respiratory diseases across severity levels, from asthma and COPD to interstitial lung disease, pulmonary hypertension, cystic fibrosis, and other pulmonary conditions. 

Covers a broad range of urologic and renal conditions including chronic kidney disease, acute kidney injury, benign prostatic hyperplasia, urinary tract infection, overactive bladder, and related disorders.

Enables evaluation of metabolic and hormonal disorders including type 2 diabetes, hypothyroidism, obesity, polycystic ovary syndrome, and Cushing’s syndrome along with other endocrine conditions. 

 

Supports research across acute and chronic infections including COVID-19, influenza, sepsis, hepatitis C, HIV, and other viral, bacterial, and parasitic diseases.

 

Accelerate study design and feasibility with real-world clinical and pharmacy data that identifies eligible patients, optimizes site selection, and informs protocol development.

Support regulatory and safety studies for external control arms, label expansions, and post-marketing surveillance by using real-world evidence on treatment patterns, adherence, and outcomes. 

Guide launch and brand strategy with insights into adoption, access barriers, provider behavior, and real-world patient journeys across integrated health system settings. 

Demonstrate value and reduce access friction with real-world evidence on utilization, adherence, outcomes, and drivers of treatment success across health system specialty pharmacies.

Generate high-quality real-world evidence on clinical outcomes, economic burden, treatment patterns, and comparative effectiveness across health system populations.

Inform scientific strategy with real-world insights on disease burden, treatment pathways, unmet needs, and patient outcomes to support evidence generation and external engagement.